Federal Supply Schedule 36F79718D0540
Award Date
8/15/18
Last Date to Order
8/14/24
Federal Agency
Veterans Integrated Service Network 12
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Vertex Pharmaceuticals Incorporated. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the Pharmaceuticals and Drugs (FSS-61-IB) contract vehicle. The contract has a ceiling value of $205,530,618.00 and a period of performance from May 1, 2024 to April 30, 2029....
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Viiv Healthcare Company, a foreign-owned for-profit manufacturer. The contract, valued at a ceiling of $1,870,730,000.00, is for the delivery of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from August 15, 2021, to August 14, 2026. This is a multiple-award contract, with no set-aside...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to Vivus LLC. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS Contract 65 I B, with a period of performance from May 1, 2019 to January 31, 2026 and a ceiling value of $5,316,660.00. The contract was awarded as a multiple-award Federal Supply Schedule, meaning Vivus LLC...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Vifor Pharma Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $85,200,000 and a period of performance extending to February 28, 2028. As a Federal Supply Schedule contract, this vehicle allows for the efficient procurement of the specified medical and pharmaceutical products by federal agencies, including...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Verity Pharmaceuticals, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the FSS-61-IB schedule, with a contract ceiling value of $225,000.00 and a period of performance through November 30, 2026. The...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Urovant Sciences Inc., a subsidiary of Sumitovant Biopharma, Inc. This multiple-award contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS-61-IB. The contract has a potential value of $700,000.00 and a period of performance through September 14, 2026. The contract aims to provide the Department...
The provided information details a Federal Supply Schedule (FSS) contract award to Aveo Pharmaceuticals, Inc. by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The $45,580,967.00 ceiling value contract has an ultimate completion date of October 14, 2026. The contract aims to procure pharmaceutical and hematology-related products to support the VA's healthcare operations. As an FSS contract, it allows for the placement of task...